Aviceda Therapeutics has secured $207.5 million in series C funds as the immunomodulator-focused biotech awaits a phase 3 ...

It is believed to be the first time that Lytenava (bevacizumab gamma) has been cleared for reimbursement in any European country, coming after ... of the retina (the macula), causing blurred ...

As part of Livewire’s annual Outlook Series, we recently asked 10 of Australia’s top fund managers to answer which industries ...

BuzzFeed Shopping writer Emma Lord loves these: "I use an electric toothbrush usually, but I feel like I'm getting a much ...

Dec. 13, 2024 — New research highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening for eye ... DNA Damage Is Key Factor ...

Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

As Americans become increasingly skeptical of technology's role in our society, can a trade show like CES help usher back an ...

However, he called those conversations very preliminary. The real discussions, though, will come soon enough. The team starts exit interviews Sunday, when the players clean out their lockers.

men’s basketball tournament to eight straight when the league kicks off its 23rd season kicks off later in the year. The team of coach Jinino Manansala ended 2024 on a high after retaining its ...

The headset won't be out until later in 2025, but it's as good a sign as any -- not to mention a warning -- of what's coming soon in ... AI has its sights set on our eyes. These ideas aren't ...